Key Market Indicators
Sales of Irish analgesic medicine are projected to reach $60 million by 2026, a decrease of 0.7% year-on-year from 2021's figure of $64.24 million. Since 2013, Ireland has seen no increase in year-on-year sales. In 2021, Ireland was ranked 17th, behind Finland at $64.24 million. Spain, Canada and Italy respectively held the 2nd, 3rd and 4th spots.
